Twist Bioscience Shares Gain 10% After Antibody Evaluation Service Announcement
Twist Bioscience announced a service to produce and quickly evaluate antibodies for AI drug discovery research. Shares rose 10% to $175.81 as of midday Wednesday.
By Elias SchisgallShares of Twist Bioscience rose after the biotechnology company announced a service that can produce and quickly evaluate antibodies for artificial-intelligence drug discovery research.Shares were up 10% at $175.81 as of midday Wednesday. The stock has more than quintupled in valu…